Bendamustine: a review of pharmacology, clinical use and immunological effects (Review)
Bendamustine: a review of pharmacology, clinical use and immunological effects (Review)
About this item
Full title
Author / Creator
Publisher
Greece: Spandidos Publications
Journal title
Language
English
Formats
Publication information
Publisher
Greece: Spandidos Publications
Subjects
More information
Scope and Contents
Contents
Bendamustine is an alkylating agent classified into the group of nitrogen mustard analogues, synthesized almost sixty years ago. It was registered in former East Germany in 1971 and approved by the US Food and Drug Administration in 2008 for treatment of chronic lymphocytic leukemia and indolent B‑cell non‑Hodgkin lymphoma. Considering its benefici...
Alternative Titles
Full title
Bendamustine: a review of pharmacology, clinical use and immunological effects (Review)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9100486
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9100486
Other Identifiers
ISSN
1021-335X,1791-2431
E-ISSN
1791-2431
DOI
10.3892/or.2022.8325
